RBC Raises Gilead Sciences Price Target to $131 From $126
RBC raised its price target on Gilead Sciences to $131 from $126 and kept its Sector Perform rating.
RBC raised its price target on Gilead Sciences to $131 from $126 and kept its Sector Perform rating.